Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07825961) titled 'Efficacy of Melatonin in the Treatment of Diabetic Nephropathy Compared With Folic Acid' on Sept. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Tanta University
Condition:
Melatonin
Diabetic Nephropathy
Folic Acid
Intervention:
Drug: Conventional diabetic treatment
Drug: Folic acid
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 1, 2025
Target Sample Size: 75
Countries of Recruitment:
Egypt
To know more, visit http...